Quest Diagnostics Incorporated (NYSE:DGX) medical laboratories diagnostic provider, is reporting third quarter earnings results on Thursday 22nd October 2020, before market open.
The consensus estimates from Thomson Reuters are income of $ 3.73 per share.
For the full year, analysts predict revenues of $ 8740.76 million, while looking forward to income of $ 8.71 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 8,400.00 million ~ $ 8,800.00 million, where as bottomline are predicted in a range of $ 7.50 ~ $ 9.00 per share
Click Here For More Historical Outlooks Of Quest Diagnostics Incorporated
Previous Quarter Performance
Quest Diagnostics Incorporated communicated income for the second quarter of $ 1.42 per share, from the revenue of $ 1,827.00 million. The quarterly earnings declined 17.92 percent while revenues declined 6.45 percent compared with the same quarter last year.
The consensus estimates are income of $ 1.40 per share from $ 1830.28 million in revenue. The bottom line results beat street analysts by $ 0.02 or 1.43 percent, at the same time, top line results fell short of analysts by $ 3.28 million or 0.18 percent.
Stock Performance
Shares of Quest Diagnostics Incorporated traded up $ 0.49 or 0.40 percent on Wednesday, reaching $ 123.81 with volume of 1.05 million shares. The stock opened positive for the day at $ 124.75, after closing the previous day trading at $ 123.32.
According to the previous trading day, closing price of $ 123.32, representing a 68.89 % increase from the 52 week low of $ 73.02 and a 6.44 % decrease over the 52 week high of $ 131.81.
The company has a market capital of $ 16.63 billion and is part of the Healthcare sector and Diagnostics & Research industry.
Recent Stock Dividend Announcement
On August 18, 2020, the board of directors authorized quarterly dividend of $ 0.56 per share to holders of record as of the close of business on October 6, 2020, with payment date of October 21, 2020 and ex-dividend date on October 5, 2020.
Conference Call
Quest Diagnostics Incorporated will be hosting a conference call at 8:30 AM eastern time on 22nd October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.questdiagnostics.com
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.
